Pfizer moves forward with weight loss pill

Pfizer plans to move a reworked, once-daily version of its danuglipron weight-loss pill into clinical trials later this year, after scrapping a twice-daily version of the drug late last year.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM